Back to search
FDAFDA · Food and drugs·Recall number D-0209-2026

Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02.

Published December 10, 2025 · Recall initiated: October 31, 2025

Summary

FDA records drug Class II recall D-0209-2026, published December 10, 2025 and initiated October 31, 2025. Recalling firm: Blossom Pharmaceuticals; Status: Ongoing; Reported quantity: 7920 bottles; Lot: Lot #: A352505. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviations

What to do

Voluntary: Firm initiated · Letter

Get an email if NIVAGEN ZINC OXIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NIVAGEN ZINC OXIDE
Manufacturer
Blossom Pharmaceuticals
Distributor
USA Nationwide
Lot
Lot #: A352505
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals, Inc., Sacramento, CA 95827, USA, Made in India, NDC 75834-170-02. recalled?

Yes. FDA published recall D-0209-2026 on December 10, 2025. Reported hazard: cGMP deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NIVAGEN ZINC OXIDE.